POST-MARKETING SURVEILLANCE OF ADVERSE REACTIONS TO NEW MEDICINES

被引：27

作者：

WILSON, AB ^{[1
]}

机构：

[1] ASSOC BRITISH PHARMACEUT IND,LONDON W1R 6DD,ENGLAND

来源：

关键词：

D O I：

10.1136/bmj.2.6093.1001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1001 / 1003

页数：3

共 25 条

[1] MONITORING ADVERSE REACTIONS TO DRUGS
ACHESON, HWK
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1977, 1 (6058): : 439 - 439
[2] BEELEY L, 1977, JUN S DRUG MON GEN P
[3] BROWN P, 1974, LANCET, V2, P1477
[4] NEW STRATEGIES FOR DRUG MONITORING
CROMBIE, DL
[J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6070) : 1217 - 1218
[5] MONITORING ADVERSE REACTIONS TO DRUGS
DOLLERY, CT
RAWLINS, MD
[J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6053) : 96 - 97
[6] DRURY M, 1977, BRIT MED J, V1, P439
[7] CUTANEOUS AND OCULAR REACTIONS TO PRACTOLOL
FELIX, RH
IVE, FA
DAHL, MGC
[J]. BRITISH MEDICAL JOURNAL, 1974, 4 (5940) : 321 - 324
[8] DRUG MONITORING AND ADVERSE REACTIONS
HOWIE, JGR
[J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6074) : 1467 - 1467
[9] INMAN WHW, 1977, JUN S DRUG MON GEN P
[10] DISCOVERY OF DRUG-INDUCED ILLNESS
JICK, H
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (09) : 481 - 485